Andrew J Brandl

Title: The Innovations of Andrew J Brandl

Introduction

Andrew J Brandl is a notable inventor based in Madison, Wisconsin. He has made significant contributions to the field of immunology through his innovative patents. With a total of three patents to his name, Brandl's work focuses on the production and differentiation of immune cells from pluripotent stem cells.

Latest Patents

One of Brandl's latest patents is titled "Antigen-specific immune effector cells." This patent provides methods for producing antigen-specific effector T cells and NK cells from pluripotent stem cells that express a chimeric antigen receptor (CAR). Additionally, it outlines methods for adoptive cell therapy by administering these effector T cells and/or NK cells. Another significant patent is "Methods for directed differentiation of pluripotent stem cells to immune cells." This patent details efficient in vitro differentiation techniques for somatic cell-derived pluripotent stem cells into hematopoietic precursor cells, which can further differentiate into various immune cells, including T cells, NK cells, and dendritic cells. Notably, this process can occur without the use of mouse feeder cells or serum under defined conditions.

Career Highlights

Andrew J Brandl is currently employed at Fujifilm Cellular Dynamics, Inc., where he continues to advance research in cellular dynamics and immunotherapy. His work has been instrumental in developing new therapeutic approaches for immune-related diseases.

Collaborations

Brandl collaborates with several talented individuals in his field, including Maksym A Vodyanyk and Xin Zhang. Their combined expertise contributes to the innovative research and development efforts at Fujifilm Cellular Dynamics, Inc.

Conclusion

Andrew J Brandl's contributions to immunology through his patents and research are paving the way for advancements in cell therapy and immune cell production. His work exemplifies the impact of innovation in the medical field.